Predictive factors for visual acuity after intravitreal triamcinolone treatment for diabetic macular edema.
about
Modulation of VEGF-induced retinal vascular permeability by peroxisome proliferator-activated receptor-β/δ.Factors affecting visual outcomes in patients with diabetic macular edema treated with ranibizumab.Macular ischemia and outcome of vitrectomy for diabetic macular edema.Macular laser photocoagulation with or without intravitreal triamcinolone pretreatment for diabetic macular edema: a result from five randomized controlled trials.Predictive factors for short-term visual outcome after intravitreal triamcinolone acetonide injection for diabetic macular oedema: an optical coherence tomography studyIntravitreal pegaptanib for the treatment of ischemic diabetic macular edema.Visual acuity and intraocular pressure after high-dose intravitreal triamcinolone acetonide in selected ocular diseases.Peroxisome proliferator-activated receptor-β/δ regulates angiogenic cell behaviors and oxygen-induced retinopathy.Intravitreal triamcinolone versus intravitreal bevacizumab for diabetic macular edema: a meta-analysis.Potential bias in ophthalmic pharmaceutical clinical trials.Diabetic macular edema: what is focal and what is diffuse?Systemic oxygen therapy versus oral enalapril for treatment of diabetic macular ischemia: a randomized controlled trial.Dosage dependency of intravitreal triamcinolone acetonide as treatment for diabetic macular oedemaNine-month results of intravitreal bevacizumab versus triamcinolone for the treatment of diffuse diabetic macular oedema: a retrospective analysis.Diabetic macular edema, innovative technologies and economic impact: New opportunities for the Lombardy Region healthcare system?Retinal vascular injuries and intravitreal human embryonic stem cell-derived haemangioblasts.Human bone marrow mesenchymal stem cells for retinal vascular injury.Intravitreal bevacizumab alone or combined with 1 mg triamcinolone in diabetic macular edema: a randomized clinical trial.Diabetic macular ischaemia is associated with narrower retinal arterioles in patients with type 2 diabetes.
P2860
Q34741796-D86E42C4-DAE6-4C6B-98B3-9C6F5AFD1583Q35050082-E7C8924F-C657-45F6-BE2F-38483A067B37Q35728048-FC3B93B0-3027-466E-93FA-0A57E0F150E5Q35947505-07C61C9F-8EC5-42DC-A3EE-748F007B3109Q35956280-FE1EB81D-B107-4061-821D-E6A6E08C408DQ36391018-461CFED1-C327-4853-AA35-835F498B977DQ36737173-0EFD0BFA-ABDE-44BB-9362-70EA2F30AFD0Q36943828-B252BA48-920D-4276-97B6-F42CF529ED7CQ37126900-1C51C5DC-C8D6-4685-8AA5-D577E9437960Q37221525-0513A867-44D7-4861-B814-B0CA74101CCBQ37261743-19754371-0482-4569-8B7C-894303CF3159Q41466339-B2EBA9FB-0169-40B6-B52C-EC0CC43FEFD1Q42116404-29474B87-AA71-407D-8B1D-AC3F8C64CB6CQ45231834-92BC5CA9-1C43-4FFD-975E-78FDD07B7955Q47250471-761F6B27-DA1B-4EEE-B3A2-555477102FC2Q48245382-741C29DA-BEB5-44C3-B4DB-FB5D5F052206Q48249626-3CFF729E-6698-4A8C-8E58-4BD206FE05FCQ53511112-EDA1F959-3258-4A09-BFE2-C6354CD05FA8Q53637738-77DA090A-6D92-4484-ADD6-8C9801C4EA2B
P2860
Predictive factors for visual acuity after intravitreal triamcinolone treatment for diabetic macular edema.
description
2005 nî lūn-bûn
@nan
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Predictive factors for visual ...... nt for diabetic macular edema.
@ast
Predictive factors for visual ...... nt for diabetic macular edema.
@en
type
label
Predictive factors for visual ...... nt for diabetic macular edema.
@ast
Predictive factors for visual ...... nt for diabetic macular edema.
@en
prefLabel
Predictive factors for visual ...... nt for diabetic macular edema.
@ast
Predictive factors for visual ...... nt for diabetic macular edema.
@en
P2093
P1433
P1476
Predictive factors for visual ...... nt for diabetic macular edema.
@en
P2093
Imren Akkoyun
Ingrid Kreissig
Peter Martus
Robert F Degenring
P304
P356
10.1001/ARCHOPHT.123.10.1338
P407
P50
P577
2005-10-01T00:00:00Z